adenosine diphosphate ribose has been researched along with DDD MPGNII in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amore, A; Banterla, F; Bettoni, S; Bresin, E; Coppo, R; Donadelli, R; Galbusera, M; Gastoldi, S; Gotti, E; Macor, P; Noris, M; Remuzzi, G; Ruggenenti, P; Tedesco, F; Tripodo, C; Valoti, E | 1 |
1 trial(s) available for adenosine diphosphate ribose and DDD MPGNII
Article | Year |
---|---|
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.
Topics: Adenosine Diphosphate Ribose; Antibodies, Monoclonal, Humanized; Atypical Hemolytic Uremic Syndrome; Complement Activation; Complement C3; Complement Membrane Attack Complex; Endothelial Cells; Female; Glomerulonephritis, Membranoproliferative; Hemolytic-Uremic Syndrome; Humans; Male; Monitoring, Physiologic; Remission Induction; Time Factors | 2014 |